A bio-fabrication approach is a novel way to develop chitosan-stabilized magnesium oxide nanomaterials (cMgO-NMs). The process involves utilizing polymeric chitosan as the reducing and stabilizing agent. The characteristics of the developed cMgO-NMs were determined using various spectroscopical techniques. Fourier-transform infrared spectroscopy (FTIR) analysis revealed crucial functional groups, Ultraviolet-visible spectroscopy (UV-Vis) spectrum showed nanomaterial development with a peak at 358 nm, and powder X-ray diffraction (PXRD) pattern confirmed a pure cubic crystalline structure. Field emission scanning electron microscopy (FE-SEM) images depicted spherical shape, while energy dispersive X-ray analysis (EDX) confirmed Mg presence. The photocatalytic efficacy of these nanomaterials in degrading dye methylene blue (MB) was examined, and the findings demonstrated the remarkable proficiency of cMgO-NMs in breaking down the dye. The cytotoxic effects of cMgO-NMs were assessed for the first time on PCI-9A and PCI-13 cancer cell lines, yielding an IC(50) value of 51 mug/mL and 42 mug/mL. The cMgO-NMs treated PCI-9A and PCI-13 cancer cells morphological changes were observed via acridine orange and ethidium bromide and DAPI staining assay, and apoptotic mode of cell death was examined through flow cytometry and comet assay. Polymeric chitosan proved effective in extensive cMgO-NMs production, showing potential as an anticancer drug, although requiring further preclinical development.
No clinical trial protocols linked to this paper
Clinical trials are automatically linked when NCT numbers are found in the paper's title or abstract.PICO Elements
No PICO elements extracted yet. Click "Extract PICO" to analyze this paper.
Paper Details
MeSH Terms
Associated Data
No associated datasets or code repositories found for this paper.
Related Papers
Related paper suggestions will be available in future updates.